黄素通过MAPK轴调节糖解路径,诱导骨髓瘤细胞的亡:一项机理学研究
Yi Wang1, Yuxi Zhang2, Yuhan Zhang3
1Faculty of Chinese Medicine and State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, Macau SAR, 999078, China.
Open life sciences
|March 12, 2026
概括
黄素通过准糖解和激活MAPK途径来抑制骨髓瘤细胞的生长. 这种天然化合物促进了亡,减少了细胞迁移,为骨髓瘤提供了潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨髓瘤是一种主要的骨癌,治疗选择有限.
- 黄素是一种天然化合物,具有抗癌性质.
- 黄素在骨髓瘤中的确切作用机制需要进一步阐明.
研究的目的:
- 为了研究黄素诱导的骨髓瘤细胞亡的机制.
- 探索糖分调节和MAPK通路在黄素作用中的作用.
- 确定黄素在骨髓瘤治疗中的关键分子标.
主要方法:
- 使用了网络药理学,蛋白质与蛋白质相互作用分析和分子对接.
- 试验室研究包括CCK-8,伤口愈合,流细胞计和TUNEL测定.
- 西方斑点分析评估了蛋白质表达水平.
主要成果:
- 库尔库抑制了骨髓瘤细胞的扩散和迁移.
- 黄素通过调高Bax和Cleaved-PARP,并降低Bcl-2的调节来诱导细胞亡.
- 黄素通过增加化P38和JNK来调节MAPK通路,同时降低糖分酶HK2和PKM2的调节.
结论:
- 黄素有效地抑制骨髓瘤细胞的生长,并诱导细胞亡.
- 该机制涉及低调糖解和JNK/P38 MAPK信号通路的激活.
- 黄素作为治疗骨髓瘤的治疗剂显示出前途.
相关概念视频
The Intrinsic Apoptotic Pathway
9.1K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K
mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
MAPK Signaling Cascades
9.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.0K
Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
The Extrinsic Apoptotic Pathway
9.2K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.2K
Apoptosis
16.6K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
16.6K


